TP53 and breast cancer: Sequencing studies analyzing somatic driver mutations in genetically complex tumors like breast cancer have identified PIK3CA as a frequently mutated gene in breast tumors followed by TP53 with co-occurrence reported in 10%–15% patients (40, 41).